• 7848 Citations
  • 45 h-Index
1986 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Craig M McDonald is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Duchenne Muscular Dystrophy Medicine & Life Sciences
Neuromuscular Diseases Medicine & Life Sciences
Spinal Cord Injuries Medicine & Life Sciences
Natural History Medicine & Life Sciences
Muscular Dystrophies Medicine & Life Sciences
Muscles Medicine & Life Sciences
Glucocorticoids Medicine & Life Sciences
Pediatrics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2011 2015

Duchenne Muscular Dystrophy
Natural History
Biomarkers
Chemical Databases
Adrenal Cortex Hormones
Duchenne Muscular Dystrophy
Outcome Assessment (Health Care)
Therapeutics
Quality of Life
Psychological Stress

Research Output 1986 2019

Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy

Hathout, Y., Liang, C., Ogundele, M., Xu, G., Tawalbeh, S. M., Dang, U. J., Hoffman, E. P., Gordish-Dressman, H., Conklin, L. S., van den Anker, J. N., Clemens, P. R., Mah, J. K., Henricson, E. K. & McDonald, C. M., Dec 1 2019, In : Scientific reports. 9, 1, 12167.

Research output: Contribution to journalArticle

Open Access
Duchenne Muscular Dystrophy
Glucocorticoids
Biomarkers
Serum
Cell Adhesion
1 Citation (Scopus)

Eteplirsen treatment attenuates respiratory decline in ambulatory and non-ambulatory patients with duchenne muscular dystrophy

Khan, N., Eliopoulos, H., Han, L., Kinane, T. B., Lowes, L. P., Mendell, J. R., Gordish-Dressman, H., Henricson, E. K. & McDonald, C. M., Jan 1 2019, In : Journal of Neuromuscular Diseases. 6, 2, p. 213-225 13 p.

Research output: Contribution to journalArticle

Open Access
Duchenne Muscular Dystrophy
Natural History
Vital Capacity
Research
Glucocorticoids

Influence of β2 adrenergic receptor genotype on risk of nocturnal ventilation in patients with Duchenne muscular dystrophy

Kelley, E. F., Cross, T. J., Snyder, E. M., McDonald, C. M., Hoffman, E. P. & Bello, L., Oct 16 2019, In : Respiratory Research. 20, 1, 221.

Research output: Contribution to journalArticle

Open Access
Duchenne Muscular Dystrophy
Adrenergic Receptors
Ventilation
Genotype
Prescriptions

Longitudinal study of upper extremity reachable workspace in fascioscapulohumeral muscular dystrophy

Hatch, M. N., Kim, K., Kurillo, G., Nicorici, A., McDonald, C. M. & Han, J. J., Jul 1 2019, In : Neuromuscular Disorders. 29, 7, p. 503-513 11 p.

Research output: Contribution to journalArticle

Muscular Dystrophies
Upper Extremity
Longitudinal Studies
Wrist
Outcome Assessment (Health Care)
1 Citation (Scopus)

Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy

the Duchenne Muscular Dystrophy Regulatory Science Consortium (D-RSC), Jan 1 2019, In : Journal of Pharmacokinetics and Pharmacodynamics.

Research output: Contribution to journalArticle

Duchenne Muscular Dystrophy
Clinical Protocols
Rare Diseases
Uncertainty
Clinical Trials